blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4027814

EP4027814 - ARTICLES AND FORMULATIONS FOR SMOKING PRODUCTS AND VAPORIZERS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  24.05.2024
Database last updated on 05.10.2024
FormerThe patent has been granted
Status updated on  16.06.2023
FormerGrant of patent is intended
Status updated on  20.02.2023
FormerRequest for examination was made
Status updated on  17.06.2022
FormerThe international publication has been made
Status updated on  20.03.2021
Most recent event   Tooltip12.07.2024Lapse of the patent in a contracting state
New state(s): IE		published on 14.08.2024  [2024/33]
Applicant(s)For all designated states
Cabbacis LLC
Post Office Box 540
Clarence NY 14031 / US
[2022/29]
Inventor(s)01 / PANDOLFINO, Joseph
Post Office Box 540 Clarence
New York 14031 / US
 [2022/29]
Representative(s)Page White Farrer
Bedford House
21a John Street
London WC1N 2BF / GB
[N/P]
Former [2023/29]Judge, Samuel David, et al
Page White & Farrer Services
Bedford House
21A John Street
London WC1N 2BF / GB
Former [2022/29]Judge, Samuel David, et al
Page White & Farrer
Bedford House
John Street
GB-London WC1N 2BF / GB
Application number, filing date20863857.710.09.2020
[2022/29]
WO2020US50128
Priority number, dateUS20191656931812.09.2019         Original published format: US201916569318
[2022/29]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021050682
Date:18.03.2021
Language:EN
[2021/11]
Type: A1 Application with search report 
No.:EP4027814
Date:20.07.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 18.03.2021 takes the place of the publication of the European patent application.
[2022/29]
Type: B1 Patent specification 
No.:EP4027814
Date:19.07.2023
Language:EN
[2023/29]
Search report(s)International search report - published on:US18.03.2021
(Supplementary) European search report - dispatched on:EP05.10.2022
ClassificationIPC:A24B13/00, C12N15/82, A01H1/02
[2022/29]
CPC:
A24B15/16 (EP,KR); A24B15/243 (KR); A24B15/302 (EP,KR);
A24B15/303 (KR); A24B15/38 (KR); A24B15/385 (EP);
A24B15/40 (KR); A24D1/002 (EP); A24D1/02 (EP,KR);
A24D1/20 (KR); A24F40/42 (EP,KR) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/29]  
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:ARTIKEL UND FORMULIERUNGENFÜR RAUCHWAREN UND VERDAMPFER[2022/29]
English:ARTICLES AND FORMULATIONS FOR SMOKING PRODUCTS AND VAPORIZERS[2022/29]
French:ARTICLES ET FORMULATIONS POUR PRODUITS À FUMER ET VAPOTEUSES[2022/29]
Entry into regional phase11.04.2022National basic fee paid 
11.04.2022Search fee paid 
11.04.2022Designation fee(s) paid 
11.04.2022Examination fee paid 
Examination procedure11.04.2022Examination requested  [2022/29]
23.11.2022Amendment by applicant (claims and/or description)
23.11.2022Date on which the examining division has become responsible
21.02.2023Communication of intention to grant the patent
08.06.2023Fee for grant paid
08.06.2023Fee for publishing/printing paid
08.06.2023Receipt of the translation of the claim(s)
Opposition(s)22.04.2024No opposition filed within time limit [2024/26]
Fees paidRenewal fee
11.04.2022Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCZ19.07.2023
HR19.07.2023
MC19.07.2023
PL19.07.2023
RO19.07.2023
RS19.07.2023
SK19.07.2023
SM19.07.2023
IE10.09.2023
NO19.10.2023
GR20.10.2023
IS19.11.2023
[2024/33]
Former [2024/28]CZ19.07.2023
HR19.07.2023
MC19.07.2023
PL19.07.2023
RO19.07.2023
RS19.07.2023
SK19.07.2023
SM19.07.2023
NO19.10.2023
GR20.10.2023
IS19.11.2023
Former [2024/23]CZ19.07.2023
HR19.07.2023
PL19.07.2023
RO19.07.2023
RS19.07.2023
SK19.07.2023
SM19.07.2023
NO19.10.2023
GR20.10.2023
IS19.11.2023
Former [2024/20]HR19.07.2023
PL19.07.2023
RS19.07.2023
SM19.07.2023
NO19.10.2023
GR20.10.2023
IS19.11.2023
Former [2024/10]HR19.07.2023
PL19.07.2023
RS19.07.2023
NO19.10.2023
GR20.10.2023
IS19.11.2023
Former [2024/09]NO19.10.2023
GR20.10.2023
IS19.11.2023
Former [2024/08]NO19.10.2023
GR20.10.2023
Documents cited:Search[A]US4676259  (ELLIS MICHAEL P [US], et al) [A] 1-10* claims 1-7 *;
 [A]US2008230088  (GUO SHUN [CN]) [A] 1-10 * the whole document *;
 [A]US8251060  (WHITE JACKIE L [US], et al) [A] 1-10 * column 1, line 63 - column 3, line 15 * * claims 1,11 *;
 [A]US8739788  (YOMTOV AMIR [US]) [A] 1-10 * claims 1-8 *;
 [A]WO2015009500  (WILLIAMS JONNIE R [US]) [A] 1-10 * paragraphs [0002] , [0003] , [0023] , [0042] * * claims 1,2,10,15 *;
 [A]US2019001087  (DAVIDSON PERRY [IL], et al) [A] 1-10 * paragraphs [0002] - [0005] - [0013] , [0021] , [0083] , [0086] , [0128] , [0221] , [0231] , [0236] , [0254] *;
 [A]US2019158938  (BOWEN ADAM [US], et al) [A] 1-10 * paragraphs [0002] , [0007] - [0008] - [0122] , [ 177] , [ 210] *;
 [A]WO2019159170  (SYQE MEDICAL LTD [IL]) [A] 1-10 * page 2, lines 9-32 * * page 3, lines 1-22 * * page 9, lines 3-15 * * page 24, lines 4-13 * * page 55, line 10 - page 56, line 10 * * claims 1-7,8,14 *;
 [AP]US2020051455  (PANDOLFINO JOSEPH [US]) [AP] 1-10 * paragraphs [0006] , [0040] - [0071] - [0172] , [0176] - [0186] *
International search[A]US4676259  (ELLIS MICHAEL P [US], et al) [A] 1-13* col 1, In 5-6, col 2, In 39-44, col 3, In 59 -61 *;
 [A]US2008230088  (GUO SHUN [CN]) [A] 1-13 * para [0004] *;
 [A]US8251060  (WHITE JACKIE L [US], et al) [A] 3 * col 12, In 12-13 *;
 [A]US8739788  (YOMTOV AMIR [US]) [A] 1-13 * col 1, In 16-24 *;
 [A]WO2015009500  (WILLIAMS JONNIE R [US]) [A] 6 * para [0004] *;
 [Y]US2019001087  (DAVIDSON PERRY [IL], et al) [Y] 6-9 * para [0003], para [0011], para [0128] *;
 [Y]US2019158938  (BOWEN ADAM [US], et al) [Y] 3 * para [0026], para [0210] *;
 [XY]WO2019159170  (SYQE MEDICAL LTD [IL]) [X] 1-2, 4-5, 10-13 * pg 2, In 9-32, pg 3, In *14-20, pg 9, In 8-12, pg 11, In 31-33, pg 23, In 17-29, pg 25, In 25-27, pg 32, In 2-4, pg 37, In 4-9, pg 43, In 16-18 * [Y] 3,6-9;
 [PX]US2020051455  (PANDOLFINO JOSEPH [US]) [PX] 1-13 * entire document *
by applicantUS3612066
 US4270552
 US5724998
 US7700368
 US8846409
 US9556142
 US9587212
 US9738622
 US9814258
 US10113174
 US10369178
    - The Journal of the American Medical Association
    - JAMA, (20180904), vol. 320, no. 9, pages 880 - 891
    - HATSUKAMI et al., Addiction, (20100000), vol. 105, no. 2, pages 343 - 55
    - ARMITAGE et al., Psychopharmacology, (19980000), vol. 96, pages 447 - 453
    - FAGERSTROM, Pharmacology, (19820000), vol. 77, pages 164 - 167
    - SISSON et al., Beitragezur Tabakforschung International, (19900600), vol. 14, no. 6
    - Production, Chemistry and Technology, (19990000), pages 377 - 379
    - ZHANG et al., Rapid Commun Mass Spectrom, (20180000), vol. 32, pages 1791 - 1798
    - LISKO et al., Anal Chem., (20130319), vol. 85, no. 6, pages 3380 - 3384
    - AYERS et al., The AAPS Journal, vol. 7, no. 3, (20050000), pages E752 - E758, URL: http://www.aapsj.org
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.